Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: Analysis of clinicopathological and molecular features and prognoses

Annals of Surgical Oncology

Volumn 17, Issue 5, 2010, Pages 1435-1441

  Kim, Young Ho ^a   Min, Byung Hoon ^a   Kim, Sue Jin ^a   Choi, Hyo Kyung ^a   Kim, Kyoung Mee ^a   Chun, Ho Kyung ^a   Lee, Hyuk ^a   Kim, Jin Yong ^a   Chang, Dong Kyung ^a   Son, Hee Jung ^a   Rhee, Poong Lyul ^a   Rhee, Jong Chul ^a   Kim, Jae J ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MLH1;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 77952091604     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0888-4     Document Type: Article

References (34)

1. CR Boland SN Thibodeau SR Hamilton, et al. 1998 A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res. 58 5248 5257 1:CAS:528:DyaK1cXnsFSmtbk%3D 9823339
2. A Umar CR Boland JP Terdiman, et al. 2004 Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability J Natl Cancer Inst. 96 261 268 1:CAS:528:DC%2BD2cXhsV2qtLk%3D 14970275 (Pubitemid 38256271)
3. K Soreide EA Janssen H Soiland H Korner JP Baak 2006 Microsatellite instability in colorectal cancer Br J Surg. 93 395 406 10.1002/bjs.5328 1:CAS:528:DC%2BD28XktFWnsL4%3D 16555243
4. A Malesci L Laghi P Bianchi, et al. 2007 Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer Clin Cancer Res. 13 3831 3839 10.1158/1078-0432.CCR-07-0366 1:CAS:528:DC%2BD2sXntFymsbc%3D 17606714 (Pubitemid 47037588)
5. JM Carethers EJ Smith CA Behling, et al. 2004 Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer Gastroenterology. 126 394 401 10.1053/j.gastro.2003.12.023 1:CAS:528: DC%2BD2cXhvV2rsbo%3D 14762775 (Pubitemid 38182296)
6. FA Sinicrope RL Rego KC Halling, et al. 2006 Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients Gastroenterology. 131 729 737 10.1053/j.gastro.2006.06.005 1:CAS:528: DC%2BD28XhtVKrurjK 16952542 (Pubitemid 44307064)
7. S Popat R Hubner RS Houlston 2005 Systematic review of microsatellite instability and colorectal cancer prognosis J Clin Oncol. 23 609 618 10.1200/JCO.2005.01.086 1:CAS:528:DC%2BD2MXitVartLY%3D 15659508 (Pubitemid 46224239)
8. CM Ribic DJ Sargent MJ Moore, et al. 2003 Tumor microsatellite- instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med. 349 247 257 10.1056/NEJMoa022289 1:CAS:528:DC%2BD3sXlsVGjsbY%3D 12867608 (Pubitemid 36859476)
9. T Watanabe TT Wu PJ Catalano, et al. 2001 Molecular predictors of survival after adjuvant chemotherapy for colon cancer N Engl J Med. 344 1196 1206 10.1056/NEJM200104193441603 1:CAS:528:DC%2BD3MXjsV2ms74%3D 11309634 (Pubitemid 32319494)
10. T Sugai W Habano YF Jiao M Tsukahara Y Takeda K Otsuka S Nakamura 2006 Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: Proposal for new molecular profile of colorectal carcinomas J Mol Diagn. 8 193 201 10.2353/jmoldx.2006.050052 1:CAS:528:DC%2BD28XltlKlsrw%3D 16645205 (Pubitemid 43811242)
11. P Gervaz P Bucher P Morel 2004 Two colons-two cancers: Paradigm shift and clinical implications J Surg Oncol. 88 261 266 10.1002/jso.20156 15565587 (Pubitemid 39601269)
12. B Iacopetta 2002 Are there two sides to colorectal cancer? Int J Cancer. 101 403 408 10.1002/ijc.10635 1:CAS:528:DC%2BD38Xnt1ehsrw%3D 12216066
13. H Elsaleh D Joseph F Grieu N Zeps N Spry B Iacopetta 2000 Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer Lancet. 355 1745 1750 10.1016/S0140-6736(00)02261-3 1:STN:280:DC%2BD3c3ptVChsw%3D%3D 10832824 (Pubitemid 30265078)
14. JA Bufill 1990 Colorectal cancer: Evidence for distinct genetic categories based on proximal or distal tumor location Ann Intern Med. 113 779 788 1:STN:280:DyaK3M%2Flt1Olug%3D%3D 2240880
15. A Lindblom 2001 Different mechanisms in the tumorigenesis of proximal and distal colon cancers Curr Opin Oncol. 13 63 69 10.1097/00001622-200101000-00013 1:STN:280:DC%2BD3M7hslKguw%3D%3D 11148689 (Pubitemid 32060047)
16. M Ilyas IP Tomlinson MR Novelli A Hanby WF Bodmer IC Talbot 1996 Clinico-pathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability J Pathol. 179 370 375 10.1002/(SICI)1096-9896(199608)179:4<370::AID-PATH627>3.0.CO;2-N 1:STN:280:DyaK2s%2Fit12hsA%3D%3D 8869282 (Pubitemid 26276104)
17. Samowitz WS, Curtin K, Wolff RK, Tripp SR, Caan BJ, Slattery ML. Microsatellite instability and survival in rectal cancer. Cancer Causes Control. 2009; in press.
18. T Watanabe T Kobunai E Toda, et al. 2006 Distal colorectal cancers with microsatellite instability (MSI) display distinct gene expression profiles that are different from proximal MSI cancers Cancer Res. 66 9804 9808 10.1158/0008-5472.CAN-06-1163 1:CAS:528:DC%2BD28XhtVyiurzE 17047040 (Pubitemid 44672030)
19. J Tanaka T Watanabe T Kanazawa T Tada Y Kazama T Tanaka H Nagawa 2007 Left-Sided microsatellite unstable colorectal cancers show less frequent methylation of hMLH1 and CpG island methylator phenotype than right-sided ones J Surg Oncol. 96 611 618 10.1002/jso.20877 1:CAS:528:DC%2BD1cXkvVWnuw%3D%3D 17786961 (Pubitemid 350191487)
20. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer staging manual. 6th ed. New York: Springer-Verlag, 2002.
21. HF Vasen P Watson JP Mecklin HT Lynch 1999 New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC Gastroenterology. 116 1453 1456 10.1016/S0016-5085(99)70510-X 1:STN:280:DyaK1M3nvVamuw%3D%3D 10348829 (Pubitemid 29258894)
22. WS Samowitz H Albertsen J Herrick, et al. 2005 Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer Gastroenterology. 129 837 845 10.1053/j.gastro.2005.06.020 1:CAS:528:DC%2BD2MXhtV2isrrE 16143123 (Pubitemid 41242676)
23. JR Jass 2007 Classification of colorectal cancer based on correlation of clinical, morphological and molecular features Histopathology. 50 113 130 10.1111/j.1365-2559.2006.02549.x 1:STN:280:DC%2BD2s%2FgvVOntw%3D%3D 17204026 (Pubitemid 44953403)
24. JP Issa 2004 CpG island methylator phenotype in cancer Nat Rev Cancer. 4 988 993 10.1038/nrc1507 1:CAS:528:DC%2BD2cXhtVarsLjK 15573120 (Pubitemid 39626222)
25. JM Hoang PH Cottu B Thuille RJ Salmon G Thomas R Hamelin 1997 BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines Cancer Res. 57 300 303 1:CAS:528:DyaK2sXntFKhtw%3D%3D 9000572 (Pubitemid 27036610)
26. M Cravo P Lage C Albuquerque, et al. 1999 BAT-26 identifies sporadic colorectal cancers with mutator phenotype: A correlative study with clinico-pathological features and mutations in mismatch repair genes J Pathol. 188 252 257 10.1002/(SICI)1096-9896(199907)188:3<252::AID-PATH354>3.0. CO;2-3 1:CAS:528:DyaK1MXltVKrur8%3D 10419591 (Pubitemid 29317766)
27. P Jernvall MJ Makinen TJ Karttunen J Makela P Vihko 1999 Microsatellite instability: Impact on cancer progression in proximal and distal colorectal cancers Eur J Cancer. 35 197 201 10.1016/S0959-8049(98)00306-2 1:STN:280:DyaK1Mznslelug%3D%3D 10448259 (Pubitemid 29136767)
28. TC Smyrk HT Lynch 1999 Microsatellite instability: Impact on cancer progression in proximal and distal colorectal cancers Eur J Cancer. 35 171 172 10.1016/S0959-8049(98)00380-3 1:STN:280:DyaK1Mznsleltg%3D%3D 10448255 (Pubitemid 29136763)
29. H Kim J Jen B Vogelstein SR Hamilton 1994 Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences Am J Pathol. 145 148 156 1:CAS:528:DyaK2cXlsFCns78%3D 8030745 (Pubitemid 24217493)
30. MM Garrity LJ Burgart MR Mahoney, et al. 2004 Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: A North Central Cancer Treatment Group Study J Clin Oncol. 22 1572 1582 10.1200/JCO.2004.10.042 1:CAS:528:DC%2BD2cXpsVWmuro%3D 15117979 (Pubitemid 41079794)
31. R Hamelin P Laurent-Puig S Olschwang, et al. 1994 Association of p53 mutations with short survival in colorectal cancer Gastroenterology. 106 42 48 1:CAS:528:DyaK2cXhs1Sitr0%3D 8276207 (Pubitemid 24011863)
32. S Tortola E Marcuello I Gonzalez, et al. 1999 p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer J Clin Oncol. 17 1375 1381 1:STN:280: DyaK1M3msFKqsg%3D%3D 10334521 (Pubitemid 29220842)
33. SM Kang K Maeda N Onoda YS Chung B Nakata Y Nishiguchi M Sowa 1997 Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis Int J Cancer. 74 502 507 10.1002/(SICI)1097-0215(19971021)74:5<502::AID- IJC4>3.0.CO;2-7 1:CAS:528:DyaK2sXmvFCksbo%3D 9355971 (Pubitemid 27486506)
34. AM Valentini R Armentano M Pirrelli ML Caruso 2006 Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: The state of the art Cancer Treat Rev. 32 607 618 10.1016/j.ctrv.2006.08.001 1:CAS:528:DC%2BD28XhtFKlsrjM 17055172 (Pubitemid 44649135)